CHGA | Chromogranin A (parathyroid secretory protein 1) | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CKB | Creatine kinase, brain | Cancer-related genes Candidate cardiovascular disease genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
CLDN4 | Claudin 4 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
COL4A2 | Collagen, type IV, alpha 2 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CSE1L | CSE1 chromosome segregation 1-like (yeast) | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
CSNK2B | Casein kinase 2, beta polypeptide | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
CSTA | Cystatin A (stefin A) | Cancer-related genes Disease related genes Plasma proteins
| | | | | Tissue enhanced |
CTAG1A | Cancer/testis antigen 1A | Cancer-related genes
| | | | | Tissue enriched |
CTNNB1 | Catenin (cadherin-associated protein), beta 1, 88kDa | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
CTSB | Cathepsin B | Cancer-related genes Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CTSD | Cathepsin D | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
CTSH | Cathepsin H | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CTSL | Cathepsin L | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CYB5R3 | Cytochrome b5 reductase 3 | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
DAXX | Death-domain associated protein | Cancer-related genes
| | | | | Expressed in all |
DDB2 | Damage-specific DNA binding protein 2, 48kDa | Cancer-related genes Disease related genes
| | | | | Expressed in all |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
EIF3H | Eukaryotic translation initiation factor 3, subunit H | Cancer-related genes
| | | | | Expressed in all |
EIF4EBP1 | Eukaryotic translation initiation factor 4E binding protein 1 | Cancer-related genes
| | | | | Expressed in all |
EIF4G1 | Eukaryotic translation initiation factor 4 gamma, 1 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
EIF4H | Eukaryotic translation initiation factor 4H | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
ENG | Endoglin | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ENO1 | Enolase 1, (alpha) | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
ENO2 | Enolase 2 (gamma, neuronal) | Cancer-related genes Candidate cardiovascular disease genes Enzymes Plasma proteins
| | | | | Expressed in all |
EPHA2 | EPH receptor A2 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enhanced |
EPHX1 | Epoxide hydrolase 1, microsomal (xenobiotic) | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
ESR1 | Estrogen receptor 1 | Cancer-related genes Disease related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
EZR | Ezrin | Cancer-related genes Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
F2 | Coagulation factor II (thrombin) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
FABP4 | Fatty acid binding protein 4, adipocyte | Cancer-related genes Plasma proteins
| | | | | Tissue enriched |
FABP5 | Fatty acid binding protein 5 (psoriasis-associated) | Cancer-related genes Plasma proteins Transporters
| | | | | Expressed in all |
FADD | Fas (TNFRSF6)-associated via death domain | Cancer-related genes Disease related genes
| | | | | Expressed in all |
FAM129A | Family with sequence similarity 129, member A | Cancer-related genes
| | | | | Expressed in all |
FASN | Fatty acid synthase | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Group enriched |
FGB | Fibrinogen beta chain | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
FGF2 | Fibroblast growth factor 2 (basic) | Cancer-related genes Candidate cardiovascular disease genes FDA approved drug targets RAS pathway related proteins
| | | | | Mixed |
FKBP5 | FK506 binding protein 5 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
FN1 | Fibronectin 1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
FOSL1 | FOS-like antigen 1 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
FSCN1 | Fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) | Cancer-related genes Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
FTL | Ferritin, light polypeptide | Cancer-related genes Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
G6PD | Glucose-6-phosphate dehydrogenase | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
GCLM | Glutamate-cysteine ligase, modifier subunit | Cancer-related genes
| | | | | Expressed in all |
GJA1 | Gap junction protein, alpha 1, 43kDa | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Mixed |
GNAS | GNAS complex locus | Cancer-related genes Disease related genes Predicted secreted proteins
| | | | | Expressed in all |
GPI | Glucose-6-phosphate isomerase | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
GSN | Gelsolin | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
GSR | Glutathione reductase | Cancer-related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
GSTM3 | Glutathione S-transferase mu 3 (brain) | Cancer-related genes Enzymes
| | | | | Expressed in all |